Table 1 Detailed general clinical data of patients.

From: Post-myocardial infarction ventricular septal defects: incidence and treatment trends during and after the COVID-19 pandemic

Patient

Sex

Age

Vsd location

EF (%)

Revascularization

IABP/ ECMO

Survival

Year

Time to surgery (days)

#1

F

60

Anterior

35

CABG on LAD

IABP + ECMO

Yes

2018

17

#2

M

75

Posterior

25

CABG on LAD, OM and RCA

IABP + ECMO

No

2019

27

#3

M

55

Posterior

30

CABG on LAD

IABP

No

2020

38

#4

F

60

Anterior

40

PCI on LAD

IABP + ECMO

Yes

2020

14

#5

M

67

Posterior

35

PCI on RCA + CABG on LAD

IABP + ECMO

Yes

2020

23

#6

F

79

Posterior

25

PCI on LAD and RCA

IABP + ECMO

No

2021

8

#7

F

65

Posterior

35

CABG on LAD, RCA and OM

IABP + ECMO

No

2021

6

#8

M

69

Posterior

40

No

IABP + ECMO

Yes

2021

9

#9

M

42

Posterior

40

CABG on LAD and RCA

IABP + ECMO

Yes

2022

5

#10

M

71

Anterior

40

CABG on LAD

IABP

Yes

2023

17

  1. VSD: ventricular septal defect, EF: ejection fraction, IABP: intra-aortic balloon pump, ECMO: extra-corporeal membrane oxygenation, CABG: coronary artery bypass grafting, PCI: percutaneous coronary intervention, CXA: circumflex artery, LAD: left anterior descending artery, LIMA: left internal mammary artery, MI: myocardial infarction, RCA: right coronary artery, TTE: trans thoracic echocardiography, VSD: ventricular septal defect.